Serena Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Serena Yu has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Caroline Susan Elizabeth Homer
Burnet Institute, Melbourne, Victoria, Australia
4 shared publications - Denzil G. Fiebig
School of Economics, University of New South Wales, Sydney, Australia
4 shared publications Rosalie Viney
University of Technology, Faculty of Health, Centre for Health Economics Research and Evaluation, Australia
4 shared publications- Rosalie Viney
University of Technology Sydney, Sydney, Australia
4 shared publications Vanessa Scarf
University of Technology, Faculty of Health, Australia
4 shared publications- Vanessa Scarf
Collective of Midwifery and Child and Family Health, University of Technology Sydney, Ultimo 2007, Australia
4 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Elsevier in SSRN Electronic Journal
Time, Money, and Infant Health: The Consequences of Paid Parental Leave
We estimate the effects of introducing paid parental leave on infant health and health care use in a setting with universal access to health care. We exploit Australia's 2011 reform through a difference-in-discontinuity design and administrative records covering all New South Wales births. We find a 1.3 and 1.2 percentage points decline in probability of any specialist visits and any prescription medications in the first year, and no effects on hospital and emergency presentations. The reduction in any medication use persist until age five and estimates are larger among young mothers who were least likely to have had employer leave. Survey data suggest that the reform eased financial strain and preserved employment, pointing to improved parental resources and time.
- 29 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessTime, Money, and Infant Health: The Consequences of Paid Parental Leave
We estimate the effects of introducing paid parental leave on infant health and health care use in a setting with universal access to health care. We exploit Australia's 2011 reform through a difference-in-discontinuity design and administrative records covering all New South Wales births. We find a 1.3 and 1.2 percentage points decline in probability of any specialist visits and any prescription medications in the first year, and no effects on hospital and emergency presentations. The reduction in any medication use persist until age five and estimates are larger among young mothers who were least likely to have had employer leave. Survey data suggest that the reform eased financial strain and preserved employment, pointing to improved parental resources and time.
- Open Access
- 11 August 2026
- Published by MDPI AG in Health Economics and Policy
- Vol. 1 (1) , 2
Why Are Cascade Birth Interventions Rising?
The increasing use of birth interventions has prompted global policy and research focus. This study attempts to enhance our understanding of why this increase is occurring. Using a population-based dataset of over 1.3 million births in New South Wales, Australia (2004–2018), we identified a growing prevalence of a “cascade” of interventions, including labour induction, epidural analgesia and either instrumental or caesarean delivery. We found that this rise has been concentrated in low-risk nulliparous women, a group that had no clinical indication or preference for intervention at labour onset. To understand this trend, we investigated the roles of maternal characteristics, hospital selection and institutional practice styles. Here, we show considerable variation in the use of a cascade of interventions at the hospital level, and that these hospital-level practice styles—and not compositional changes in the characteristics of women giving birth, nor their hospital choices—account for much of the increase in the use of cascade interventions over time. These findings highlight the importance of institutional factors in shaping clinical care, and suggest new directions for policy and research.
- 11 August 2026
- Published by MDPI AG in Health Economics and Policy
- Vol. 1 (1) , 2
Open AccessWhy Are Cascade Birth Interventions Rising?
The increasing use of birth interventions has prompted global policy and research focus. This study attempts to enhance our understanding of why this increase is occurring. Using a population-based dataset of over 1.3 million births in New South Wales, Australia (2004–2018), we identified a growing prevalence of a “cascade” of interventions, including labour induction, epidural analgesia and either instrumental or caesarean delivery. We found that this rise has been concentrated in low-risk nulliparous women, a group that had no clinical indication or preference for intervention at labour onset. To understand this trend, we investigated the roles of maternal characteristics, hospital selection and institutional practice styles. Here, we show considerable variation in the use of a cascade of interventions at the hospital level, and that these hospital-level practice styles—and not compositional changes in the characteristics of women giving birth, nor their hospital choices—account for much of the increase in the use of cascade interventions over time. These findings highlight the importance of institutional factors in shaping clinical care, and suggest new directions for policy and research.
- Open Access
- 16 May 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (5) , 283
Healthcare Resource Use and Costs of Allogeneic Hematopoietic Stem Cell Transplantation Complications: A Scoping Review
Allogeneic hematopoietic stem cell transplant (allo-HSCT) is an expensive and resource intensive procedure. This study aims to review the literature pertaining to healthcare resource utilization (HRU) and costs associated with allo-HSCT complications. The review followed the Joanna Briggs Institute methodology for scoping reviews. The PubMed, EMBASE, and Health Business Elite were searched in addition to the grey literature. Eligibility criteria included studies that reported HRU and/or costs associated with adult (≥18 years) allo-HSCT. Studies were categorized according to complications of allo-HSCT including graft-versus-host disease (acute and chronic GVHD) and infections (fungal, cytomegalovirus, virus-associated hemorrhagic cystitis, and acute respiratory tract infection). Commonly reported HRU and cost measures were extracted, including those associated with the direct management of allo-HSCT complications and intensive care unit (ICU) admissions. Reported costs were standardized to 2022 United States Dollars. Patients who experienced GVHD or infection post-transplant had an overall greater HRU including higher rates of hospitalization, hospital readmission, ICU admission, and longer length of stay compared to those patients who did not. Patients with severe or refractory GVHD and/or infection following allo-HSCT required greater healthcare intervention. This scoping review synthesizes the current literature on HRU and costs associated with post allo-HSCT complications. Patients who experienced post allo-HSCT complications had higher HRU and incurred higher costs overall, noting the variability across studies in their clinical context, reporting of HRU, and cost measures.
- 16 May 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (5) , 283
Open AccessHealthcare Resource Use and Costs of Allogeneic Hematopoietic Stem Cell Transplantation Complications: A Scoping Review
Allogeneic hematopoietic stem cell transplant (allo-HSCT) is an expensive and resource intensive procedure. This study aims to review the literature pertaining to healthcare resource utilization (HRU) and costs associated with allo-HSCT complications. The review followed the Joanna Briggs Institute methodology for scoping reviews. The PubMed, EMBASE, and Health Business Elite were searched in addition to the grey literature. Eligibility criteria included studies that reported HRU and/or costs associated with adult (≥18 years) allo-HSCT. Studies were categorized according to complications of allo-HSCT including graft-versus-host disease (acute and chronic GVHD) and infections (fungal, cytomegalovirus, virus-associated hemorrhagic cystitis, and acute respiratory tract infection). Commonly reported HRU and cost measures were extracted, including those associated with the direct management of allo-HSCT complications and intensive care unit (ICU) admissions. Reported costs were standardized to 2022 United States Dollars. Patients who experienced GVHD or infection post-transplant had an overall greater HRU including higher rates of hospitalization, hospital readmission, ICU admission, and longer length of stay compared to those patients who did not. Patients with severe or refractory GVHD and/or infection following allo-HSCT required greater healthcare intervention. This scoping review synthesizes the current literature on HRU and costs associated with post allo-HSCT complications. Patients who experienced post allo-HSCT complications had higher HRU and incurred higher costs overall, noting the variability across studies in their clinical context, reporting of HRU, and cost measures.
- Open Access
- 11 April 2025
- Published by Elsevier in Journal of Health Economics
- Vol. 102, 102995
The impact of neonatal care on moderate-risk infants: Evidence from healthcare use in the first two years of life
- 11 April 2025
- Published by Elsevier in Journal of Health Economics
- Vol. 102, 102995
Open AccessThe impact of neonatal care on moderate-risk infants: Evidence from healthcare use in the first two years of life
- Open Access
- 22 January 2024
- Published by Wiley in Health Economics
- Vol. 33 (5) , 911-928
Physician responses to insurance benefit restrictions: The case of ophthalmology
This study examines the impact of social insurance benefit restrictions on physician behaviour, using ophthalmologists as a case study. We examine whether ophthalmologists use their market power to alter their fees and rebates across services to compensate for potential policy‐induced income losses. The results show that ophthalmologists substantially reduced their fees and rebates for services directly targeted by the benefit restriction compared to other medical specialists' fees and rebates. There is also some evidence that they increased their fees for services that were not targeted. High‐fee charging ophthalmologists exhibited larger fee and rebate responses while the low‐fee charging group raise their rebates to match the reference price provided by the policy environment.
- 22 January 2024
- Published by Wiley in Health Economics
- Vol. 33 (5) , 911-928
Open AccessPhysician responses to insurance benefit restrictions: The case of ophthalmology
This study examines the impact of social insurance benefit restrictions on physician behaviour, using ophthalmologists as a case study. We examine whether ophthalmologists use their market power to alter their fees and rebates across services to compensate for potential policy‐induced income losses. The results show that ophthalmologists substantially reduced their fees and rebates for services directly targeted by the benefit restriction compared to other medical specialists' fees and rebates. There is also some evidence that they increased their fees for services that were not targeted. High‐fee charging ophthalmologists exhibited larger fee and rebate responses while the low‐fee charging group raise their rebates to match the reference price provided by the policy environment.
- 24 June 2023
- Published by Elsevier in Social Science & Medicine
- Vol. 330, 116041
Provider responses to the expansion of public subsidies in healthcare: The case of oral chemotherapy treatment in Australia
- 24 June 2023
- Published by Elsevier in Social Science & Medicine
- Vol. 330, 116041
Provider responses to the expansion of public subsidies in healthcare: The case of oral chemotherapy treatment in Australia
- 16 January 2023
- Published by Elsevier in The Journal of Pediatrics
- Vol. 258, 113327
Preterm Birth and Total Health Care Use and Costs in the First 5 Years of Life: A Population-based Study
- 16 January 2023
- Published by Elsevier in The Journal of Pediatrics
- Vol. 258, 113327
Preterm Birth and Total Health Care Use and Costs in the First 5 Years of Life: A Population-based Study
- 19 January 2022
- Published by Elsevier in Social Science & Medicine
- Vol. 294, 114729
Private provider incentives in health care: The case of caesarean births
- 19 January 2022
- Published by Elsevier in Social Science & Medicine
- Vol. 294, 114729
Private provider incentives in health care: The case of caesarean births
- Open Access
- 14 August 2021
- Published by Springer Nature in BMC Health Services Research
- Vol. 21 (1) , 1-11
Modelling the cost of place of birth: a pathway analysis
Background: In New South Wales (NSW), Australia there are three settings available for women at low risk of complications to give birth: home, birth centre and hospital. Between 2000 and 2012, 93.6% of babies were planned to be born in hospital, 6.0% in a birth centre and 0.4% at home. Availability of alternative birth settings is limited and the cost of providing birth at home or in a birth centre from the perspective of the health system is unknown.Objectives: The objective of this study was to model the cost of the trajectories of women who planned to give birth at home, in a birth centre or in a hospital from the public sector perspective.Methods: This was a population-based study using linked datasets from NSW, Australia. Women included met the following selection criteria: 37-41 completed weeks of pregnancy, spontaneous onset of labour, and singleton pregnancy at low risk of complications. We used a decision tree framework to depict the trajectories of these women and Australian Refined-Diagnosis Related Groups (AR-DRGs) were applied to each trajectory to estimate the cost of birth. A scenario analysis was undertaken to model the cost for 30 000 women in one year.Findings: 496 387 women were included in the dataset. Twelve potential outcome pathways were identified and each pathway was costed using AR-DRGs. An overall cost was also calculated by place of birth: $AUD4802 for homebirth, $AUD4979 for a birth centre birth and $AUD5463 for a hospital birth.Conclusion: The findings from this study provides some clarity into the financial saving of offering more options to women seeking an alternative to giving birth in hospital. Given the relatively lower rates of complex intervention and neonatal outcomes associated with women at low risk of complications, we can assume the cost of providing them with homebirth and birth centre options could be cost-effective.
- 14 August 2021
- Published by Springer Nature in BMC Health Services Research
- Vol. 21 (1) , 1-11
Open AccessModelling the cost of place of birth: a pathway analysis
Background: In New South Wales (NSW), Australia there are three settings available for women at low risk of complications to give birth: home, birth centre and hospital. Between 2000 and 2012, 93.6% of babies were planned to be born in hospital, 6.0% in a birth centre and 0.4% at home. Availability of alternative birth settings is limited and the cost of providing birth at home or in a birth centre from the perspective of the health system is unknown.Objectives: The objective of this study was to model the cost of the trajectories of women who planned to give birth at home, in a birth centre or in a hospital from the public sector perspective.Methods: This was a population-based study using linked datasets from NSW, Australia. Women included met the following selection criteria: 37-41 completed weeks of pregnancy, spontaneous onset of labour, and singleton pregnancy at low risk of complications. We used a decision tree framework to depict the trajectories of these women and Australian Refined-Diagnosis Related Groups (AR-DRGs) were applied to each trajectory to estimate the cost of birth. A scenario analysis was undertaken to model the cost for 30 000 women in one year.Findings: 496 387 women were included in the dataset. Twelve potential outcome pathways were identified and each pathway was costed using AR-DRGs. An overall cost was also calculated by place of birth: $AUD4802 for homebirth, $AUD4979 for a birth centre birth and $AUD5463 for a hospital birth.Conclusion: The findings from this study provides some clarity into the financial saving of offering more options to women seeking an alternative to giving birth in hospital. Given the relatively lower rates of complex intervention and neonatal outcomes associated with women at low risk of complications, we can assume the cost of providing them with homebirth and birth centre options could be cost-effective.
- 1 December 2020
- Published by Elsevier in Health Policy
- Vol. 124 (12) , 1395-1402
Birth models of care and intervention rates: The impact of birth centres
- 1 December 2020
- Published by Elsevier in Health Policy
- Vol. 124 (12) , 1395-1402
Birth models of care and intervention rates: The impact of birth centres